ALL · Allstate Corp - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $16.94B | - | $17.25B | $16.63B | $16.45B | - | $16.63B | $15.71B | $15.26B | - |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | - | - | - | - | - | - | - | - | - | - |
| Total Operating Expenses | - | - | - | - | - | - | - | - | - | - |
| D&A | - | - | - | - | - | - | - | - | - | - |
| Operating Income | - | - | - | - | - | - | - | - | - | - |
| Interest Expense | - | - | - | - | - | - | - | - | $97.00M | - |
| Income Tax | $650.00M | - | $1.07B | $604.00M | $123.00M | - | $254.00M | $83.00M | $266.00M | - |
| Net Income | $2.46B | - | $3.75B | $2.11B | $595.00M | - | $1.19B | $331.00M | $1.22B | - |
| EPS - Basic | $9.36 | - | $14.13 | $7.86 | $2.13 | - | $4.39 | $1.14 | $4.51 | - |
| EPS - Diluted | $9.25 | - | $13.95 | $7.76 | $2.11 | - | $4.33 | $1.13 | $4.46 | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $697.00M | $678.00M | $931.00M | $995.00M | $840.00M | $704.00M | $816.00M | $599.00M | $850.00M | $722.00M |
| Accounts Receivable | - | - | - | - | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - | - | - | - | - |
| Accounts Payable | - | - | - | - | - | - | - | - | - | - |
| Current Assets | - | - | - | - | - | - | - | - | - | - |
| Total Assets | $123.97B | $119.76B | $120.40B | $115.89B | $115.16B | $111.62B | $113.74B | $108.37B | $105.24B | $103.36B |
| Current Liabilities | - | - | - | - | - | - | - | - | - | - |
| Long-term Debt | $7.49B | $7.49B | $8.09B | $8.09B | $8.09B | $8.09B | $8.08B | $8.08B | $7.94B | $7.94B |
| Total Liabilities | $92.39B | $89.17B | $92.91B | $91.89B | $93.11B | $90.25B | $92.91B | $89.80B | $86.76B | $85.73B |
| Stockholders' Equity | $31.61B | $30.61B | $27.50B | $24.02B | $22.05B | $21.44B | $20.88B | $18.59B | $18.64B | $17.77B |
| Retained Earnings | $64.54B | $62.39B | $58.85B | $55.40B | $53.59B | $53.29B | $51.63B | $50.72B | $50.66B | $49.72B |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $3.56B | - | - | - | $1.96B | - | - | - | $1.67B | - |
| Investing Cash Flow | ($2.63B) | - | - | - | ($1.29B) | - | - | - | ($1.37B) | - |
| Financing Cash Flow | ($916.00M) | - | - | - | ($334.00M) | - | - | - | ($166.00M) | - |
| CapEx | $40.00M | - | - | - | $92.00M | - | - | - | $41.00M | - |
| Free Cash Flow | $3.52B | - | - | - | $1.87B | - | - | - | $1.63B | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | - | - | - | - |
| Operating margin | - | - | - | - | - | - | - | - | - | - |
| EBITDA margin | - | - | - | - | - | - | - | - | - | - |
| Net margin | 14.5% | - | 21.7% | 12.7% | 3.6% | - | 7.2% | 2.1% | 8.0% | - |
| Free cash flow margin | 20.8% | - | - | - | 11.4% | - | - | - | 10.6% | - |
| FCF / Net income | 1.43 | - | - | - | 3.15 | - | - | - | 1.33 | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | - | - | - | - | - | - | - | - | - | - |
| Effective tax rate | 20.9% | - | 22.3% | 22.3% | 17.1% | - | 17.6% | 20.0% | 17.9% | - |
| Return on assets | 2.0% | - | 3.1% | 1.8% | 0.5% | - | 1.0% | 0.3% | 1.2% | - |
| Return on equity | 7.8% | - | 13.6% | 8.8% | 2.7% | - | 5.7% | 1.8% | 6.5% | - |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | - | - | - | - | - | - | - | - | - | - |
| Quick ratio | - | - | - | - | - | - | - | - | - | - |
| Cash ratio | - | - | - | - | - | - | - | - | - | - |
| Leverage | ||||||||||
| Debt / Equity | 0.24 | 0.24 | 0.29 | 0.34 | 0.37 | 0.38 | 0.39 | 0.43 | 0.43 | 0.45 |
| Debt / Assets | 0.06 | 0.06 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.08 | 0.08 |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | - | - | - | - | - | - | - | - | - | - |
| Equity multiplier | 3.92 | 3.91 | 4.38 | 4.83 | 5.22 | 5.21 | 5.45 | 5.83 | 5.65 | 5.82 |
| Liabilities / Assets | 0.75 | 0.74 | 0.77 | 0.79 | 0.81 | 0.81 | 0.82 | 0.83 | 0.82 | 0.83 |
| Efficiency | ||||||||||
| Asset turnover | 0.14 | - | 0.14 | 0.14 | 0.14 | - | 0.15 | 0.15 | 0.14 | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | 22.4x | - | 15.4x | 25.9x | 98.1x | - | 43.8x | 141.3x | 38.8x | - |
| P / B | 1.7x | - | 2.1x | 2.2x | 2.5x | - | 2.4x | 2.3x | 2.5x | - |
| P / S | 3.2x | - | 3.3x | 3.2x | 3.4x | - | 3.1x | 2.7x | 3.0x | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 3.0% | - | 3.8% | 5.8% | 7.8% | - | 14.7% | 12.4% | 10.7% | - |
| Revenue CAGR (3y) | 7.1% | - | 9.3% | 10.8% | 10.1% | - | 10.0% | 7.5% | 7.0% | - |
| Revenue CAGR (5y) | 6.4% | - | 8.5% | 8.2% | 10.3% | - | 8.5% | 7.1% | 6.8% | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Net income growth (YoY) | 312.9% | - | 214.8% | 537.2% | -51.1% | - | - | - | - | - |
| EPS growth (YoY) | 338.4% | - | 222.2% | 586.7% | -52.7% | - | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | -2.0% | - | 36.3% | -40.1% | - | - |
| EPS CAGR (5y) | - | - | 31.3% | 15.0% | 5.8% | - | 10.2% | -14.3% | 3.6% | - |
| FCF growth (YoY) | 88.1% | - | - | - | 15.2% | - | - | - | 211.3% | - |
| FCF CAGR (5y) | 21.6% | - | - | - | 14.2% | - | - | - | 20.7% | - |
| Book value growth (YoY) | 43.3% | 42.8% | 31.7% | 29.2% | 18.3% | 20.7% | 43.1% | 19.8% | 6.5% | 1.7% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$64.27B totalProperty Liability$59.73B · 92.9%
Protection Services$3.55B · 5.5%
Allstate Health And Benefits$676.00M · 1.1%
Corporate And Other$308.00M · 0.5%
Peer comparison
Same SIC group: Fire, Marine & Casualty Insurance
Comparing ALLSTATE CORP against the 5 most active filers in the same SIC group.
Dividends
$5.16/share trailing 12 months · +81.7% YoY
| Ex-date | Per share |
|---|---|
| Jun 1, 2026 | $1.0800 |
| Mar 2, 2026 | $1.0800 |
| Dec 1, 2025 | $1.0000 |
| Aug 29, 2025 | $1.0000 |
| Jun 9, 2025 | $1.0000 |
| Mar 10, 2025 | $1.0000 |
| Nov 29, 2024 | $0.9200 |
| Aug 30, 2024 | $0.9200 |
| May 31, 2024 | $0.9200 |
| Mar 1, 2024 | $0.9200 |
| Nov 29, 2023 | $0.8900 |
| Aug 30, 2023 | $0.8900 |
| Jun 1, 2023 | $0.8900 |
| Feb 27, 2023 | $0.8900 |
| Nov 29, 2022 | $0.8500 |
| Aug 30, 2022 | $0.8500 |
| Jun 2, 2022 | $0.8500 |
| Feb 25, 2022 | $0.8500 |
| Nov 29, 2021 | $0.8100 |
| Aug 30, 2021 | $0.8100 |
| Jun 3, 2021 | $0.8100 |
| Mar 3, 2021 | $0.8100 |
| Nov 27, 2020 | $0.5400 |
| Aug 27, 2020 | $0.5400 |